Reimbursement Data is information on what payors actually pay for procedures and services — the allowed amounts behind billed claims. It moves beyond how often a procedure happens to how much it pays, a critical input for market and expansion decisions.
Paired with healthcare claims data, reimbursement data lets teams weigh volume against value when prioritizing markets and procedures.
Volume alone can mislead. A high-volume procedure that reimburses poorly may be less attractive than a lower-volume, well-reimbursed one. Reimbursement Data adds the financial dimension, letting MedTech, diagnostics, and provider groups evaluate opportunity by both demand and economics.
For practices considering expansion or new service lines, reimbursement data answers the bottom-line question: is this procedure worth offering in this market? — grounding investment decisions in real payment economics.
Reimbursement data is information on what payors actually pay for procedures and services — the allowed amounts behind claims. It shows the financial value of procedures, complementing volume data with the economics needed for market and expansion decisions.
Overlay reimbursement rates on procedure volume from claims data: volume shows how often a procedure happens, reimbursement shows what each one pays. Together they reveal total economic opportunity, so teams prioritize procedures that are both common and well-paid.
It answers whether a procedure or service line is financially worth offering in a given market. By combining demand (volume) with value (reimbursement), practices and vendors avoid investing in high-volume but low-margin opportunities.
The allowed amount is the specific figure a payor approves for a service; reimbursement data is the broader dataset of these amounts across procedures, payors, and geographies. Allowed amounts are the building blocks of reimbursement data.